Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 2004

View Archived Issues

Vasogen highlights FY 2003 developments

CuraGen continues to advance pipeline of protein, antibody and small molecule therapeutics

Low levels of free testosterone may increase risk of Alzheimer disease

Migraine sufferers with aura and at least one attack per month at risk for cerebral infarction

CE Mark for Matritech NMP22 products

Ivax's generic glyburide/metformin hydrochloride receives approval

Pfizer discontinues development of DK-507k

GeneMax acquires license to novel assay technology

Enrollment completed in phase IIa IPL-512602 study

OraDisc A NDA accepted for filing

Phenanthrene-based glucocorticoid receptor modulators newly developed at Pfizer

Alrex safe for long-term treatment of seasonal allergic conjunctivitis

Novel cholesterol absorption inhibitors discovered at AstraZeneca

Novartis presents new modulators of Smac/IAP interaction

New tubulysin conjugates for cancer therapy claimed by Morphochem

Phase I trial of PT-523 commences enrollment

New protein kinase inhibitors for cancer therapy designed at Novartis

Novartis presents novel tyrosine kinase inhibitors with utility in leukemia

New antitumor fredericamycin derivatives discovered at Biofrontera

New program for Protherics' Angiotensin Vaccine

Novel probucol derivatives with improved PK profile presented by AtheroGenics team

Surfaxin selected for CMA Pilot 2 Program

Clinical benefits induced by roflumilast in the treatment of asthma

Promising phase III results found for indiplon in chronic insomnia

Preliminary efficacy results of a Zadaxin triple therapy in hepatitis C

Poor efficacy reported for vaccines against HIV infection

Yamanouchi and Fujisawa announce agreement to merge in 2005

NPC1L1 identified as a protein involved in intestinal cholesterol absorption and action of ezetimibe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...